FDA inspection
Jiangsu Hansoh Pharmaceutical Group Co., Ltd: FDA inspection ending Jun 13, 2019
FDA inspection 1094745 · Voluntary Action Indicated (VAI) · Lianyungang
Key facts
| Inspection ID | 1094745 |
|---|---|
| Firm | Jiangsu Hansoh Pharmaceutical Group Co., Ltd |
| FEI number | 3008316144 |
| Address | Dev. Zone, Economic And Tech ; 5 Dongjin Road |
| City | Lianyungang |
| Country | China |
| Fiscal year | 2019 |
| Inspection end date | Jun 13, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data